Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis

Published:2014-12-03 Issue:12 Volume:9 Page:e114483
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Weber Daniel G.,Casjens Swaantje,Johnen Georg,Bryk Oleksandr,Raiko Irina,Pesch Beate,Kollmeier Jens,Bauer Torsten T.,Brüning Thomas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Malignant pleural mesothelioma: an epidemiological perspective;BM Robinson;Ann Cardiothorac Surg,2012

2. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003;B Price;Am J Epidemiol,2004

3. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050;JT Hodgson;Br J Cancer,2005

4. Future trends of mesothelioma mortality in Japan based on a risk function;T Myojin;Ind Health,2012

5. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;NJ Vogelzang;J Clin Oncol,2003

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Logistic regression and other statistical tools in diagnostic biomarker studies;Clinical and Translational Oncology;2024-03-26

2. The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis;Pulmonology;2024-02

3. Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis;PLOS ONE;2022-10-14

4. MicroRNA Biomarkers of Malignant Mesothelioma;Genomic and Epigenomic Biomarkers of Toxicology and Disease;2022-04-27

5. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study;Clinica Chimica Acta;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3